TRANSPLANTATION PROCEEDINGS, vol.48, no.6, pp.2157-2161, 2016 (SCI-Expanded)
Introduction. Donor organ shortage is still a problem for heart transplantation. Only 10% of patients in waiting list undergo heart transplantation. Over the last 5 years, 2 different continuous flow pumps, the HeartMate II and the HeartWare, have been successful clinically in the alternative treatment of patients with end-stage heart disease.